<code id='D1943AE31E'></code><style id='D1943AE31E'></style>
    • <acronym id='D1943AE31E'></acronym>
      <center id='D1943AE31E'><center id='D1943AE31E'><tfoot id='D1943AE31E'></tfoot></center><abbr id='D1943AE31E'><dir id='D1943AE31E'><tfoot id='D1943AE31E'></tfoot><noframes id='D1943AE31E'>

    • <optgroup id='D1943AE31E'><strike id='D1943AE31E'><sup id='D1943AE31E'></sup></strike><code id='D1943AE31E'></code></optgroup>
        1. <b id='D1943AE31E'><label id='D1943AE31E'><select id='D1943AE31E'><dt id='D1943AE31E'><span id='D1943AE31E'></span></dt></select></label></b><u id='D1943AE31E'></u>
          <i id='D1943AE31E'><strike id='D1943AE31E'><tt id='D1943AE31E'><pre id='D1943AE31E'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:412
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Alabama IVF ruling threatens families facing fatal genetic disease
          Alabama IVF ruling threatens families facing fatal genetic disease

          Henrywithhisparents.Illustration:STAT;Courtesy:AllenGoldbergWhenmywife,Laurie,completedherninthinvit

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Ed Silverman on new gene therapies, biosimilars, coffee, and more

          STAT'sEdSilvermanonstageattheSTATBreakthroughSummitin2023.SarahGonzalezforSTATIn2023,STATlaunchedabr